Utilization of vasopressors and ino tropes in cardiac surgery were derived from published data from 3 hospitals in Denmark1 and 55 hospitals in the United States,2 extracted from national registries in each country and representing 5,975 patients combined who underwent cardiac surgery. The Denmark cohort included patients undergoing coronary artery bypass grafting, valve-surgery, combinations, and thoracic aortic procedures from January 2007 to December 2008. The United States cohort included high-risk patients for coronary artery bypass grafting and valve-surgery combinations from January 2004 to June 2005.

Infographic created by Jonathan P. Wanderer, Vanderbilt University School of Medicine, and James P. Rathmell, Massachusetts General Hospital/Harvard Medical School. Background art by B. A. Campbell; final layout by Annemarie Johnson, Vivo Visuals. Address correspondence to Dr. Wanderer: jon.wanderer@vanderbilt.edu.

1.
Nielsen
DV
,
Johnsen
SP
,
Madsen
M
,
Jakobsen
CJ
:
Variation in use of peroperative inotropic support therapy in cardiac surgery: Time for reflection? Acta Anaesthesiol Scand 2011;.
55
:
352
8
2.
Hernandez
AF
,
Li
S
,
Dokholyan
RS
,
O’Brien
SM
,
Ferguson
TB
,
Peterson
ED
:
Variation in perioperative vasoactive therapy in cardiovascular surgical care: Data from the Society of Thoracic Surgeons. Am Heart J 2009;.
158
:
47
52